About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
Quant Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSMS Pharmaceuticals Limited9.981390807134.9789
Domestic EquitiesANTHEM BIOSCIENCES LIMITED9.255046250932.4334
Domestic EquitiesSequent Scientific Limited9.0475148799731.7062
Domestic EquitiesAster DM Healthcare Limited8.343544667129.2391
Domestic EquitiesZydus Wellness Ltd7.048364173024.7002
Domestic EquitiesPfizer Ltd6.92704795424.2753
Domestic EquitiesAlivus Life Sciences6.408324629822.4575
Domestic EquitiesICICI Prudential Life Insurance Co Ltd5.557929759119.4773
Domestic EquitiesHDFC Life Insurance Co Ltd4.647722770016.2874
Domestic EquitiesAurobindo Pharma Limited4.537613030015.9018
Domestic EquitiesMedplus Health Services Limited3.629715007112.7200
Domestic EquitiesConcord Biotech Limited2.90748347210.1886
Domestic EquitiesGlaxosmithkline Pharmaceuticals Ltd2.3848324988.3572
Domestic EquitiesGland Pharma Limited1.4599280765.1160
Total 82.1358 287.8389
Cash & Cash Equivalents and Net AssetsTREPS 02-Mar-2026 DEPO 1010.63123726737.2564
Cash & Cash Equivalents and Net AssetsNCA-NET CURRENT ASSETS-16.2338 -56.8902
Total -5.6026 -19.6338
Treasury Bills91 Days Treasury Bill 22-May-20261.69206000005.9294
Treasury Bills91 Days Treasury Bill 23-Apr-20260.84953000002.9770
Treasury Bills91 Days Treasury Bill 30-Apr-20260.84863000002.9740
Treasury Bills91 Days Treasury Bill 07-May-20260.84783000002.9710
Treasury Bills91 Days Treasury Bill 14-May-20260.84693000002.9680
Treasury Bills91 Days Treasury Bill 27-Mar-20260.56872000001.9930
Treasury Bills91 Days Treasury Bill 05-Mar-20260.28521000000.9993
Treasury Bills91 Days Treasury Bill 17-Apr-20260.28341000000.9932
Total 6.2221 21.8049
Derivatives-FuturesAurobindo Pharma Limited5.355215290018.7669
Derivatives-FuturesBiocon Ltd4.892643750017.1456
Derivatives-FuturesHDFC Life Insurance Co Ltd4.494321890015.7499
Derivatives-FuturesICICI Prudential Life Insurance Co Ltd1.94581036006.8190
Total 16.6879 58.4814
RightsAdani Enterprises Limited PP RE0.5568113991.9513
Total 0.5568 1.9513
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.